[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nanopharmaceuticals Market Research Report 2016

September 2016 | 124 pages | ID: GEC008B776DEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Nanopharmaceuticals

Revenue, means the sales value of Nanopharmaceuticals

This report studies Nanopharmaceuticals in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
  • Merck
  • Pfizer
  • Novartis
  • Abbott
  • GlaxoSmithKline
  • Roche
  • Sanofi
  • Eli Lilly
  • Astrazeneca
  • Johnson & Johnson
  • Celgene
  • Novavax
  • Stryker
  • Gilead Sciences
  • OSI Pharmaceuticals
  • Kadmon Pharmaceuticals
  • Samyang Biopharm
  • Mitsubishi Pharma
  • Kaken Pharmaceutical
  • Selecta Biosciences
  • Par Pharmaceutical
  • Cerulean Pharma
  • Navidea Biopharmaceuticals
  • Lummy
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nanopharmaceuticals in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Liposomes
  • Polymeric micelles
  • Solid lipid nanoparticles
  • Microemulsion and nanoemulsion
  • Nanosuspension
Split by application, this report focuses on consumption, market share and growth rate of Nanopharmaceuticals in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Nanopharmaceuticals Market Research Report 2016

1 NANOPHARMACEUTICALS MARKET OVERVIEW

1.1 Product Overview and Scope of Nanopharmaceuticals
1.2 Nanopharmaceuticals Segment by Type
  1.2.1 Global Production Market Share of Nanopharmaceuticals by Type in 2015
  1.2.2 Liposomes
  1.2.3 Polymeric micelles
  1.2.4 Solid lipid nanoparticles
  1.2.5 Microemulsion and nanoemulsion
  1.2.6 Nanosuspension
1.3 Nanopharmaceuticals Segment by Application
  1.3.1 Nanopharmaceuticals Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Nanopharmaceuticals Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nanopharmaceuticals (2011-2021)

2 GLOBAL NANOPHARMACEUTICALS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Nanopharmaceuticals Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nanopharmaceuticals Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nanopharmaceuticals Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nanopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nanopharmaceuticals Market Competitive Situation and Trends
  2.5.1 Nanopharmaceuticals Market Concentration Rate
  2.5.2 Nanopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NANOPHARMACEUTICALS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Nanopharmaceuticals Capacity and Market Share by Region (2011-2016)
3.2 Global Nanopharmaceuticals Production and Market Share by Region (2011-2016)
3.3 Global Nanopharmaceuticals Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NANOPHARMACEUTICALS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Nanopharmaceuticals Consumption by Regions (2011-2016)
4.2 North America Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NANOPHARMACEUTICALS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Nanopharmaceuticals Production and Market Share by Type (2011-2016)
5.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2011-2016)
5.3 Global Nanopharmaceuticals Price by Type (2011-2016)
5.4 Global Nanopharmaceuticals Production Growth by Type (2011-2016)

6 GLOBAL NANOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION

6.1 Global Nanopharmaceuticals Consumption and Market Share by Application (2011-2016)
6.2 Global Nanopharmaceuticals Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NANOPHARMACEUTICALS MANUFACTURERS PROFILES/ANALYSIS

7.1 Merck
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Nanopharmaceuticals Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Merck Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Pfizer
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Nanopharmaceuticals Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Pfizer Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Novartis
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Nanopharmaceuticals Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Novartis Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Abbott
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Nanopharmaceuticals Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Abbott Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 GlaxoSmithKline
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Nanopharmaceuticals Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 GlaxoSmithKline Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Roche
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Nanopharmaceuticals Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Roche Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Sanofi
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Nanopharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Sanofi Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Eli Lilly
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Nanopharmaceuticals Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Eli Lilly Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Astrazeneca
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Nanopharmaceuticals Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Astrazeneca Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Johnson & Johnson
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Nanopharmaceuticals Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Johnson & Johnson Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Celgene
7.12 Novavax
7.13 Stryker
7.14 Gilead Sciences
7.15 OSI Pharmaceuticals
7.16 Kadmon Pharmaceuticals
7.17 Samyang Biopharm
7.18 Mitsubishi Pharma
7.19 Kaken Pharmaceutical
7.20 Selecta Biosciences
7.21 Par Pharmaceutical
7.22 Cerulean Pharma
7.23 Navidea Biopharmaceuticals
7.24 Lummy

8 NANOPHARMACEUTICALS MANUFACTURING COST ANALYSIS

8.1 Nanopharmaceuticals Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nanopharmaceuticals

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Nanopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NANOPHARMACEUTICALS MARKET FORECAST (2016-2021)

12.1 Global Nanopharmaceuticals Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Nanopharmaceuticals Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Nanopharmaceuticals Production Forecast by Type (2016-2021)
12.4 Global Nanopharmaceuticals Consumption Forecast by Application (2016-2021)
12.5 Nanopharmaceuticals Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Nanopharmaceuticals
Figure Global Production Market Share of Nanopharmaceuticals by Type in 2015
Figure Product Picture of Liposomes
Table Major Manufacturers of Liposomes
Figure Product Picture of Polymeric micelles
Table Major Manufacturers of Polymeric micelles
Figure Product Picture of Solid lipid nanoparticles
Table Major Manufacturers of Solid lipid nanoparticles
Figure Product Picture of Microemulsion and nanoemulsion
Table Major Manufacturers of Microemulsion and nanoemulsion
Figure Product Picture of Nanosuspension
Table Major Manufacturers of Nanosuspension
Table Nanopharmaceuticals Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Nanopharmaceuticals Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Nanopharmaceuticals Capacity of Key Manufacturers (2015 and 2016)
Table Global Nanopharmaceuticals Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Nanopharmaceuticals Capacity of Key Manufacturers in 2015
Figure Global Nanopharmaceuticals Capacity of Key Manufacturers in 2016
Table Global Nanopharmaceuticals Production of Key Manufacturers (2015 and 2016)
Table Global Nanopharmaceuticals Production Share by Manufacturers (2015 and 2016)
Figure 2015 Nanopharmaceuticals Production Share by Manufacturers
Figure 2016 Nanopharmaceuticals Production Share by Manufacturers
Table Global Nanopharmaceuticals Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Nanopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Nanopharmaceuticals Revenue Share by Manufacturers
Table 2016 Global Nanopharmaceuticals Revenue Share by Manufacturers
Table Global Market Nanopharmaceuticals Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Nanopharmaceuticals Average Price of Key Manufacturers in 2015
Table Manufacturers Nanopharmaceuticals Manufacturing Base Distribution and Sales Area
Table Manufacturers Nanopharmaceuticals Product Type
Figure Nanopharmaceuticals Market Share of Top 3 Manufacturers
Figure Nanopharmaceuticals Market Share of Top 5 Manufacturers
Table Global Nanopharmaceuticals Capacity by Regions (2011-2016)
Figure Global Nanopharmaceuticals Capacity Market Share by Regions (2011-2016)
Figure Global Nanopharmaceuticals Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Nanopharmaceuticals Capacity Market Share by Regions
Table Global Nanopharmaceuticals Production by Regions (2011-2016)
Figure Global Nanopharmaceuticals Production and Market Share by Regions (2011-2016)
Figure Global Nanopharmaceuticals Production Market Share by Regions (2011-2016)
Figure 2015 Global Nanopharmaceuticals Production Market Share by Regions
Table Global Nanopharmaceuticals Revenue by Regions (2011-2016)
Table Global Nanopharmaceuticals Revenue Market Share by Regions (2011-2016)
Table 2015 Global Nanopharmaceuticals Revenue Market Share by Regions
Table Global Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Nanopharmaceuticals Consumption Market by Regions (2011-2016)
Table Global Nanopharmaceuticals Consumption Market Share by Regions (2011-2016)
Figure Global Nanopharmaceuticals Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Nanopharmaceuticals Consumption Market Share by Regions
Table North America Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Europe Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table China Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Japan Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table India Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Global Nanopharmaceuticals Production by Type (2011-2016)
Table Global Nanopharmaceuticals Production Share by Type (2011-2016)
Figure Production Market Share of Nanopharmaceuticals by Type (2011-2016)
Figure 2015 Production Market Share of Nanopharmaceuticals by Type
Table Global Nanopharmaceuticals Revenue by Type (2011-2016)
Table Global Nanopharmaceuticals Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Nanopharmaceuticals by Type (2011-2016)
Figure 2015 Revenue Market Share of Nanopharmaceuticals by Type
Table Global Nanopharmaceuticals Price by Type (2011-2016)
Figure Global Nanopharmaceuticals Production Growth by Type (2011-2016)
Table Global Nanopharmaceuticals Consumption by Application (2011-2016)
Table Global Nanopharmaceuticals Consumption Market Share by Application (2011-2016)
Figure Global Nanopharmaceuticals Consumption Market Share by Application in 2015
Table Global Nanopharmaceuticals Consumption Growth Rate by Application (2011-2016)
Figure Global Nanopharmaceuticals Consumption Growth Rate by Application (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Nanopharmaceuticals Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Nanopharmaceuticals Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Nanopharmaceuticals Market Share (2011-2016)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Nanopharmaceuticals Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Nanopharmaceuticals Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Nanopharmaceuticals Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Nanopharmaceuticals Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Nanopharmaceuticals Market Share (2011-2016)
Table Astrazeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astrazeneca Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astrazeneca Nanopharmaceuticals Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Nanopharmaceuticals Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nanopharmaceuticals
Figure Manufacturing Process Analysis of Nanopharmaceuticals
Figure Nanopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nanopharmaceuticals
Table Distributors/Traders List
Figure Global Nanopharmaceuticals Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Nanopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table Global Nanopharmaceuticals Production Forecast by Regions (2016-2021)
Table Global Nanopharmaceuticals Consumption Forecast by Regions (2016-2021)
Table Global Nanopharmaceuticals Production Forecast by Type (2016-2021)
Table Global Nanopharmaceuticals Consumption Forecast by Application (2016-2021)


More Publications